Aurobindo Pharma working on developing several viral vaccines including one for COVID-19

07 Aug 2020 Evaluate

Aurobindo Pharma is working on developing several viral vaccines including one for COVID-19 even as the candidate was approved for funding by the Department of BioTechnology. During the year (FY20), the company has further strengthened its presence in the vaccines segment through the acquisition of R&D assets from Profectus Biosciences through Auro Vaccines. Using those R&D assets, the team is working on developing several viral vaccines, including a vaccine for COVID-19.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1082.00 -11.00 (-1.01%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.